AdVita Lifescience
AdVita Lifescience was sold to RELIEF THERAPEUTICS Holding AG
RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief"), a biopharmaceutical company with its lead compound RLF-100TM (Aviptadil) in advanced clinical development to treat severe COVID-19 patients buys AdVita Lifescience GmbH ("AdVita"), a Germany-based, privately held pharmaceutical company developing effective products and strategies to improve the treatment and diagnosis of rare lung diseases.
RELIEF THERAPEUTICS Holding AG
Hoffmann & Partner
We support and professionally manage the M&A process from the first steps to the successful transaction. In doing our work we are accustomed to outmost discretion and swift execution. We help our clients making company value potentials visible and realizing them in transactions. Life sciences and high-tech transactions: We know how to sell (and acquire) technologies and we specialise in complex international transactions of technology companies. M&A in the regional service and industrial sectors of Switzerland: As the leading M&A firm in the Basel area, we are very experienced with company sales and acquisitions in the regional industries of Northwestern Switzerland and neighbouring economic regions. Many of these transactions are international.
+41 61 485 93 00
ubreitenstein@hoffmann-partner.com
http://hoffmann-partner.com/en/
